Long-acting injectables help patients overcome stigma and adherence barriers in HIV care, explained Matthew H. Herrmann, MD, AAHIVS. Long-acting injectable (LAI) HIV medications are reshaping how ...

Bayesian spatiotemporal modeling showed HOLC grades C and D had significantly lower adjusted screening odds versus grade A, despite no unadjusted grade differences. Median screening prevalence ...

Crossover dosing with commercially available THC gummies used a validated marker of lane control as the primary end point, alongside reaction time, speed variability, willingness to drive, perceived ...

An infectious disease specialist discusses HIV prevention barriers facing Black women and how long-acting options and education can close gaps. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...

Cardiac diagnoses and all-cause mortality do not carry the same evidentiary weight in an observational study, and Eman A. Toraih, MD, PhD, wants clinicians to know the difference.

An infectious disease specialist discusses HIV prevention barriers facing Black women and how long-acting options and ...

Christos Vaklavas, MD, discusses geographic and telehealth barriers to cancer care access across Utah and the broader ...

Selinexor achieved a 35% or greater spleen volume reduction in 17% of patients at week 24, and in 23% at any point during ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

Among cause-specific cardiovascular deaths, evolocumab showed directionally favorable effects for acute MI, stroke, and heart ...

NHANES cross-sectional modeling showed cardiovascular health associated with lower overactive bladder prevalence. Component ...

Among 56,978 Dutch adults, occupational irritants (OR, 1.19), cleaning products (1.25), and mites (1.41) tracked with ...